https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-06-19 / Oncology 2019 Jun;:1-14
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-06-19 / Oncology 2019 Jun;:1-142019-06-19 00:00:002019-06-19 00:00:00Predicted Markers of Overall Survival in Pancreatic Cancer Patients Receiving Dendritic Cell Vaccinations Targeting WT1
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-06-17 / J Clin Oncol 37, 2019 (suppl; abstr e13526)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-06-17 / J Clin Oncol 37, 2019 (suppl; abstr e13526)2019-06-17 11:50:402019-07-17 11:53:03Safety of nivolumab in combination with dendritic cell vaccines in recurrent high-grade glioma.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-06-14 / Br J Clin Pharmacol 2019 Aug;85(8):1670-1683
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-06-14 / Br J Clin Pharmacol 2019 Aug;85(8):1670-16832019-06-14 00:00:002023-03-07 12:45:44Assessing the impact of the addition of dendritic cell vaccination to neoadjuvant chemotherapy in breast cancer patients: A model-based characterization approach
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-06-06 / Ther Apher Dial 2019 Jun;23(3):279-288
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-06-06 / Ther Apher Dial 2019 Jun;23(3):279-2882019-06-06 00:00:002019-06-06 00:00:00Phase I/II Pilot Study of Wilms‘ Tumor 1 Peptide-Pulsed Dendritic Cell Vaccination Combined With Conventional Chemotherapy in Patients With Head and Neck Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-06-03 / J Clin Oncol 37, 2019 (suppl; abstr 9538)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-06-03 / J Clin Oncol 37, 2019 (suppl; abstr 9538)2019-06-03 00:00:002020-08-26 12:15:23A phase II open labeled, randomized study of poly-ICLC matured dendritic cells for NY-ESO-1 and Mean-A peptide vaccination compared to Montanide, in melanoma patients in complete clinical remission.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-06-02 / J Clin Oncol 37, 2019 (suppl; abstr 9039)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-06-02 / J Clin Oncol 37, 2019 (suppl; abstr 9039)2019-06-02 00:00:002020-05-06 15:07:38Dendritic-cell vaccine (DCVAC) with first-line chemotherapy in patients with stage IV NSCLC: Final analysis of phase II, open label, randomized, multicenter trial.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-06-01 / J Clin Oncol 37, 2019 (suppl; abstr 2639)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-06-01 / J Clin Oncol 37, 2019 (suppl; abstr 2639)2019-06-01 00:00:002019-06-01 00:00:00Preliminary results of a phase I clinical trial using an autologous dendritic cell cancer vaccine targeting HER2 in patients with metastatic cancer or operated high-risk bladder cancer (NCT01730118).
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-05-31 / J Clin Oncol 37, 2019 (suppl; abstr e15748)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-05-31 / J Clin Oncol 37, 2019 (suppl; abstr e15748)2019-05-31 00:00:002020-05-06 15:03:38Combination therapy of dendritic cell vaccination plus chemotherapy in pancreatic cancer.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-05-31 / Melanoma Manag 2019 May;6(2):MMT20
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-05-31 / Melanoma Manag 2019 May;6(2):MMT202019-05-31 00:00:002019-05-31 00:00:00Patient-specific dendritic cell vaccines with autologous tumor antigens in 72 patients with metastatic melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-05-31 / J Clin Oncol 37, 2019 (suppl; abstr e21024)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-05-31 / J Clin Oncol 37, 2019 (suppl; abstr e21024)2019-05-31 00:00:002020-05-06 15:04:34Dendritic cell vaccination in metastatic uveal melanoma as compassionate treatment: Immunological and clinical responses.
